ENTITY

Merck KGaA (MRK GY)

7
Analysis
Health CareGermany
Merck KGaA is a global pharmaceutical and chemicals company. The Company researches drugs in the areas oncology and neurodegenerative as well as autoimmune and inflammatory diseases. Also, it markets cardiovascular, fertility, endocrinology, and over-the-counter products as well as products for flat screens and the pharmaceutical, food, cosmetics, packaging, and coatings.
more
bullishMSCI ACWI Index
17 Aug 2018 23:22

Global Strategy: Carnage Continuation Amid Turkey Turmoil and US Dollar Breakout

Corrections across global ex-US markets continue to limit attractive investment opportunities from both a price and relative strength perspective. ...

Logo
601 Views
Share
bullishMSCI ACWI Index
27 Jul 2018 02:23

Global Strategy: Health Care Outperforming - Overweight; India Breaking Out -Add Exposure

Today's report puts a spotlight on the Health Care Sector, which is assuming a global leadership role vs. other Sectors. We also focus on...

Logo
680 Views
Share
29 Nov 2017 20:09

Invest in Life: The Latest (Corporate) Development in the Australian IVF Industry

As their biological clock ticks on, many women in their 30s begin to worry about having a baby before it's too late.  Now there is a way to put a...

Logo
247 Views
Share
28 Nov 2017 16:52

Drugs Evolving Into 'Biological Software' to Boost Moribund Pharma Sector?

The global pharma and biotech sector has underperformed by about four points this year, and five over three years – the divergence with other...

Logo
325 Views
Share
bullishLG Display
03 Jun 2017 02:32

Update on LG Display's Flexible OLED Situation

LG Display Co Ltd (034220 KS) is now hitting 52-week highs. It'd not be hard to make a reasonable guess on why its price is going strong now. The...

Logo
405 Views
Share
x